APODEX LAB · #043

APODEX LAB · #043

Reaction & Synthesis Discovery

·

Chemo-enzymatic route feasibility

Chemo-enzymatic retrosynthesis + per-step enzyme recommendation

Can a chemo-enzymatic route with per-step enzyme recommendation achieve above 50% overall yield, and does executed yield match prediction within 15%?
Chemo-enzymatic retrosynthesis + per-step enzyme recommendationchiral aminecarbonylaryl ketone

THE QUESTION

For a named target molecule, can a chemo-enzymatic route with per-step enzyme recommendation reach above 50% overall yield when executed — and does executed yield match prediction within 15%?
The catalytic penalty paid when similarity-assigned enzymes meet route-imposed operating conditions.

WORK ORDER

Catalytic efficiency and operational half-life across a 16-enzyme panel under route-imposed conditions

BACKGROUND

What this Apodex Lab is

Synthetic routes that combine chemical and biocatalytic transformations offer shorter pathways to complex molecules, but planning them requires enzymes to operate on unfamiliar substrates under harsh chemical conditions. When automated synthesis planners assign a specific recombinant enzyme to a step, they typically choose the closest match to a known reaction and assume it will function as catalogued. In practice, an enzymatic transformation sits between chemical steps that leave behind residual co-solvents, extremes of pH from acid or base workups, and elevated operating temperatures. If the selected catalyst cannot tolerate the window imposed by its neighbouring steps, the planned synthesis fails to achieve the conversion required for an economical process.

Published synthesis tools defend their recommendations on retrosynthetic grounds, reporting top-k agreement with curated libraries of roughly 8,000 enzymatic reactions and high algorithmic confidence scores. These benchmarks report plausibility rather than executed chemical yield. Process chemistry targets overall yields above 50%, yet the firmest published multi-step chemo-enzymatic benchmark sits near 40% across five steps without per-step kinetic records. Literature turnover numbers span eleven orders of magnitude and are recorded near optimum conditions, typically pH 7–8 and 25–37 °C in aqueous buffer. What remains unmeasured is the paired drop in catalytic efficiency when an enzyme chosen by sequence or reaction similarity is run on the exact non-native intermediate under the specific pH, temperature, and co-solvent mixture that the surrounding chemical steps dictate.

The Chemo-enzymatic retrosynthesis + per-step enzyme recommendation Apodex Lab commissions initial-rate kinetic assays across a 16-enzyme divergence panel covering two reaction families: an omega-transaminase converting a prochiral aryl-alkyl ketone to a chiral primary amine, and a ketoreductase converting a beta-keto ester to a chiral secondary alcohol. Expressing recombinant enzymes in Escherichia coli, the assay measures the change in log10(kcat/Km) and the operational half-life between a neutral reference condition and the route-imposed operating window. If the measured condition penalty exceeds 1.5 log10 units, route designers must re-engineer the flanking chemical steps or derate published kinetic numbers before committing to synthesis. If the penalty is negligible, development effort can move directly to isolated step yields rather than off-optimum enzyme qualification.

WHY NOW

Why the field is spending on an assumption

Computer-aided route planning now suggests specific recombinant enzymes for individual reaction steps rather than generic reaction classes. These proposals rely on retrosynthetic metrics, such as recovering known routes from curated libraries of roughly 8,000 reactions, but report route quality as plausibility rather than executed yield. The firmest published multi-step chemo-enzymatic benchmark reaches about 40% overall yield across five steps. Each proposed enzymatic step must operate within conditions set by flanking chemical steps, spanning pH 4–10, temperatures from 20–70 °C, and organic co-solvents, while catalogued enzyme kinetics exist only near optimal conditions, typically pH 7–8 and 25–37 °C. How much catalytic efficiency drops under route-imposed conditions remains unmeasured.

WHAT WE’D BUY

What we would ask a laboratory to run

We are not buying the answer. We are buying a measurement with an interval — and the bars it will be compared against.

Sixteen recombinant enzymes across two reaction families (an omega-transaminase converting an aryl-alkyl ketone to a chiral primary amine, and a ketoreductase converting a beta-keto ester to a chiral secondary alcohol) are expressed in Escherichia coli, purified, and assayed. Initial-rate kinetics are measured on the route intermediates under reference conditions (pH 7.5, 30 °C, aqueous) and under route-imposed pH, temperature, and co-solvents. The measurement returns the pooled paired change in catalytic efficiency, Δlog10(kcat/Km) in log10 M⁻¹s⁻¹ units, with a 95% confidence interval half-width no greater than 0.30 log10 across 16 usable pairs, or 0.35 log10 at the 12-pair floor. First-order operational half-lives and upper-bound fractional conversions in the allowed residence time are determined for each enzyme.

SCOPE & LIMITS

Assaying purified recombinant enzymes in buffer at analytical scale provides an upper bound on conversion that identifies failing steps, but does not guarantee performance in crude process streams at scale.

WHO EXECUTES

The kind of lab that can run this

A synthetic-and-biocatalysis contract research organisation able to express or purchase the named recombinant enzymes, run kcat/Km assays across pH 4–10 and 20–70 °C on non-native substrates, and carry out small-scale one-pot chemical steps with HPLC/GC yield quantification.

EXECUTOR KIND

wet-lab

THIS APODEX LAB’S GENERATIONS

ISSUED

Compiled and scoped. Where every Apodex Lab stands today.

NOT YET OPEN

Opens when the measurement returns from the bench.

UNWRITTEN

Shaped by what Generation 1 measures.

WAYS IN

FOR PIs, LABS & CROs

Complete tasks no model can.

Paid per task, credited by name — a “Verified by” line for as long as the discovery it settled exists. You choose the work: browse the tasks above, respond to what you can actually run.

CREATE AN APODEX LAB

Have a question of your own?

Give it its own laboratory. Watch it decompose into an executable manifest.

ASK A FOLLOW-UP QUESTION

Push on our assumptions.

Every Apodex Lab lists what it doesn’t know. Good questions compound.

Every Apodex Lab shares the same verified-knowledge ledger. No laboratory works alone.